Vitamin Shoppe Inc (NYSE:VSI) – Equities research analysts at Gabelli upped their FY2020 EPS estimates for shares of Vitamin Shoppe in a research report issued on Thursday, November 8th. Gabelli analyst D. Witkowski now anticipates that the specialty retailer will post earnings of $0.50 per share for the year, up from their prior estimate of $0.45. Gabelli also issued estimates for Vitamin Shoppe’s FY2021 earnings at $0.80 EPS and FY2022 earnings at $1.10 EPS.
VSI has been the subject of several other reports. ValuEngine upgraded Vitamin Shoppe from a “hold” rating to a “buy” rating in a report on Wednesday, August 8th. Zacks Investment Research upgraded Vitamin Shoppe from a “sell” rating to a “hold” rating in a report on Wednesday, August 1st. Barclays lowered Vitamin Shoppe from an “equal weight” rating to an “underweight” rating in a report on Friday, September 7th. Finally, Morgan Stanley began coverage on Vitamin Shoppe in a report on Monday, September 17th. They issued an “equal weight” rating and a $14.00 target price for the company.
Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, November 7th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.08. Vitamin Shoppe had a positive return on equity of 3.48% and a negative net margin of 1.41%. The business had revenue of $276.64 million during the quarter, compared to analyst estimates of $278.79 million.
In related news, CEO Sharon M. Leite bought 5,500 shares of Vitamin Shoppe stock in a transaction that occurred on Friday, August 31st. The stock was purchased at an average cost of $12.64 per share, for a total transaction of $69,520.00. Following the acquisition, the chief executive officer now owns 5,500 shares in the company, valued at $69,520. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 18.50% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Shah Capital Management lifted its holdings in Vitamin Shoppe by 3.7% in the 2nd quarter. Shah Capital Management now owns 4,273,342 shares of the specialty retailer’s stock worth $29,699,000 after purchasing an additional 153,342 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Vitamin Shoppe by 10.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock worth $7,288,000 after purchasing an additional 158,123 shares during the last quarter. FMR LLC increased its position in Vitamin Shoppe by 49.7% in the 2nd quarter. FMR LLC now owns 1,624,543 shares of the specialty retailer’s stock worth $11,290,000 after buying an additional 539,100 shares during the period. GMT Capital Corp bought a new position in Vitamin Shoppe in the 2nd quarter worth approximately $7,991,000. Finally, WINTON GROUP Ltd bought a new position in Vitamin Shoppe in the 3rd quarter worth approximately $6,581,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.
About Vitamin Shoppe
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.